Viravecs Labs’ Founders Dr Rohan H Kamat & Dr Srikanth Budnar
Genome editing encompasses an array of recently developed technologies with a wide application in the Life Sciences industry, and has the potential to be used as therapeutics in future.
These techniques give researchers tools to precisely alter gene function to study their role, or alternatively create disease models for drug discovery and pharmacological studies.
Dr Rohan Kamat (33) and Dr Srikanth Budnar (36) incorporated Bangalore-based Viravecs Labs in 2014 with the sole aim of being pioneers in genome editing in India.
Dr Rohan and Dr Srikanth obtained their PhDs from ACTREC-TMC (The Advanced Centre for Treatment, Research and Education in Cancer - Tata Memorial Centre), the research arm of popularly known Tata Memorial Hospital in Mumbai.
Post his PhD, Dr Rohan spent 3 years as a DST-Cognitive Science Initiative (CSI) post-doctoral research fellow at NCBS (National Centre for Biological Sciences) in Bangalore.